Dr. Michael Lattanzi
What this data tells you about Dr. Lattanzi
Dr. Michael Lattanzi is a medical oncology in Austin, TX, with 9 years in practice. Based on federal Medicare data, Dr. Lattanzi performed 98,260 Medicare services across 2,689 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lattanzi received a total of $155,982 from 20 pharmaceutical and/or device companies across 212 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lattanzi is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Darbepoetin injection (Aranesp) for anemia | 18,180 | $2 | $20 |
| Pembrolizumab injection (Keytruda) | 17,200 | $43 | $137 |
| Paclitaxel chemotherapy injection | 14,103 | $0 | $8 |
| Anti-nausea injection (fosaprepitant) | 13,650 | $0 | $5 |
| Contrast dye for imaging (iodine-based) | 10,150 | $0 | $3 |
| Iron sucrose injection (Venofer) | 9,600 | $0 | $2 |
| Anti-nausea injection (aprepitant) | 2,730 | $1 | $8 |
| Denosumab injection (Prolia/Xgeva) | 1,980 | $18 | $66 |
| Dexamethasone injection (steroid) | 1,759 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,280 | $1 | $114 |
| Injection, granisetron hydrochloride, 100 mcg | 820 | $0 | $24 |
| Injection, carboplatin, 50 mg | 471 | $2 | $300 |
| Injection of additional new drug or substance into vein | 417 | $13 | $108 |
| Comprehensive metabolic blood panel | 398 | $10 | $64 |
| Complete blood count (CBC) with differential | 381 | $8 | $36 |
| Administration of chemotherapy into vein, 1 hour or less | 370 | $108 | $707 |
| Blood draw (venipuncture) | 299 | $8 | $20 |
| Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 276 | $82 | $1,348 |
| Injection, magnesium sulfate, per 500 mg | 258 | $1 | $6 |
| Magnesium level test | 235 | $7 | $29 |
| Injection, potassium chloride, per 2 meq | 220 | $0 | $1 |
| Injection, zoledronic acid, 1 mg | 199 | $7 | $431 |
| Administration of chemotherapy into vein, each additional hour | 178 | $23 | $161 |
| Office visit, established patient (30-39 min) | 176 | $100 | $368 |
| Injection, fluorouracil, 500 mg | 158 | $2 | $13 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 140 | $24 | $157 |
| Office visit, established patient, complex (40-54 min) | 139 | $140 | $496 |
| Drug injection, under skin or into muscle | 135 | $11 | $96 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 132 | $51 | $313 |
| Administration of additional new drug or substance into vein, 1 hour or less | 131 | $53 | $344 |
| Injection, diphenhydramine hcl, up to 50 mg | 124 | $1 | $7 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 112 | $16 | $94 |
| Unclassified drugs | 111 | $1 | $8 |
| Office visit, established patient (20-29 min) | 110 | $72 | $250 |
| Hospital follow-up visit, low complexity | 108 | $37 | $135 |
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 103 | $301 | $2,762 |
| Thyroid stimulating hormone (TSH) test | 93 | $16 | $80 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 91 | $60 | $211 |
| Infusion, normal saline solution , 1000 cc | 90 | $2 | $19 |
| CT scan of abdomen and pelvis with contrast | 87 | $184 | $1,067 |
| Ct scan of chest with contrast | 83 | $48 | $821 |
| Hospital follow-up visit, moderate complexity | 66 | $61 | $247 |
| Initial hospital admission, moderate complexity | 64 | $101 | $470 |
| Lactate dehydrogenase (enzyme) level | 44 | $6 | $31 |
| Ferritin level test (iron stores) | 43 | $13 | $60 |
| Iron level test | 43 | $6 | $27 |
| Iron binding capacity test | 43 | $9 | $35 |
| Infusion into a vein for hydration, each additional hour | 42 | $10 | $75 |
| PSA test (prostate cancer screening) | 39 | $18 | $94 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 39 | $28 | $145 |
| Microscopic examination for white blood cells with manual cell count | 38 | $4 | $22 |
| Complete blood count (CBC), automated | 38 | $6 | $34 |
| Testosterone (hormone) level, total | 33 | $25 | $143 |
| Infusion into a vein for hydration, 31-60 minutes | 33 | $26 | $256 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 31 | $17 | $100 |
| Measurement of immunoglobulin light chains | 30 | $17 | $60 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 30 | $1 | $19 |
| New patient office visit, complex (60-74 min) | 28 | $169 | $709 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | 27 | $197 | $700 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | 26 | $196 | $700 |
| Administration of additional new drug or substance into vein using push technique | 24 | $46 | $289 |
| Application of on-body injector for under skin injection | 23 | $15 | $96 |
| Red blood count automated, with additional calculations | 22 | $5 | $26 |
| New patient office visit (30-44 min) | 22 | $89 | $372 |
| Reticulated (young) platelet measurement | 20 | $35 | $143 |
| New patient office visit (45-59 min) | 20 | $133 | $565 |
| Drawing of blood for a medical problem | 19 | $72 | $264 |
| Hospital follow-up visit, high complexity | 19 | $94 | $357 |
| Irrigation of implanted venous access drug delivery device | 18 | $16 | $114 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 17 | $136 | $500 |
| CT scan of chest, without contrast | 16 | $43 | $686 |
| Ct scan of abdomen and pelvis without contrast | 13 | $77 | $560 |
| Injection of drug or substance into vein | 13 | $31 | $247 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (92%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in medical oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 10% for medical oncology in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Lattanzi is a mixed practice specialist, with above-average Medicare volume (top 10% in TX), and high industry engagement (speaking/promotional, top 10%).
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Lattanzi experienced with darbepoetin injection (aranesp) for anemia?
Does Dr. Lattanzi receive payments from pharmaceutical companies?
How do Dr. Lattanzi's costs compare to other medical oncologys in Austin?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology